# A Safety and Effectiveness Study of Paliperidone Palmitate in Chinese Patients With Schizophrenia

> **NCT01947803** · PHASE4 · COMPLETED · sponsor: **Xian-Janssen Pharmaceutical Ltd.** · enrollment: 353 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Paliperidone Palmitate

## Key facts

- **NCT ID:** NCT01947803
- **Lead sponsor:** Xian-Janssen Pharmaceutical Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 353 (ACTUAL)
- **Last updated:** 2016-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01947803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01947803, "A Safety and Effectiveness Study of Paliperidone Palmitate in Chinese Patients With Schizophrenia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01947803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*